NO20045217L - Anvendelse av tio-oxindolderivater for behandling av hormon relaterte tilstander - Google Patents
Anvendelse av tio-oxindolderivater for behandling av hormon relaterte tilstanderInfo
- Publication number
- NO20045217L NO20045217L NO20045217A NO20045217A NO20045217L NO 20045217 L NO20045217 L NO 20045217L NO 20045217 A NO20045217 A NO 20045217A NO 20045217 A NO20045217 A NO 20045217A NO 20045217 L NO20045217 L NO 20045217L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- formula
- thio
- hormone
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39182602P | 2002-06-25 | 2002-06-25 | |
PCT/US2003/019710 WO2004000225A2 (en) | 2002-06-25 | 2003-06-23 | Use of thio-oxindole derivatives in treatment of hormone-related conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20045217L true NO20045217L (no) | 2005-03-15 |
Family
ID=30000758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20045217A NO20045217L (no) | 2002-06-25 | 2004-11-29 | Anvendelse av tio-oxindolderivater for behandling av hormon relaterte tilstander |
Country Status (17)
Country | Link |
---|---|
US (3) | US7488734B2 (es) |
EP (1) | EP1531806A4 (es) |
JP (1) | JP2005535623A (es) |
CN (1) | CN1662234A (es) |
AR (1) | AR040339A1 (es) |
AU (1) | AU2003245637A1 (es) |
BR (1) | BR0312054A (es) |
CA (1) | CA2489813A1 (es) |
CR (1) | CR7610A (es) |
EC (1) | ECSP055574A (es) |
IL (1) | IL165395A0 (es) |
MX (1) | MXPA04012419A (es) |
NO (1) | NO20045217L (es) |
RU (1) | RU2005101635A (es) |
TW (1) | TW200407124A (es) |
WO (1) | WO2004000225A2 (es) |
ZA (1) | ZA200410409B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6407101B1 (en) | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
US6391907B1 (en) * | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
US6355648B1 (en) | 1999-05-04 | 2002-03-12 | American Home Products Corporation | Thio-oxindole derivatives |
US6509334B1 (en) * | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
UA73119C2 (en) * | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
IL165395A0 (en) * | 2002-06-25 | 2006-01-15 | Wyeth Corp | Use of thio-oxubdile derivatives in treatment of hormone-related conditions |
RU2006132180A (ru) * | 2004-04-07 | 2008-05-20 | Вайет (Us) | Кристаллический полиморф базедоксифен ацетата |
JP2007532548A (ja) * | 2004-04-07 | 2007-11-15 | ワイス | バゼドキシフェンアセテートの結晶質多形体 |
JP4869221B2 (ja) | 2004-04-08 | 2012-02-08 | ワイス・エルエルシー | プロゲステロン受容体調節剤としてのチオアミド誘導体 |
CA2561313C (en) * | 2004-04-08 | 2012-12-04 | Wyeth | Methods for minimizing thioamide impurities |
WO2005120432A1 (en) * | 2004-06-07 | 2005-12-22 | Duramed Pharmaceuticals, Inc. | Dispenser for progestin used for acute and maintenance treatment of dub |
GT200500185A (es) * | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
MY158766A (en) | 2005-04-11 | 2016-11-15 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their uses as therapeutic agents |
AR053710A1 (es) | 2005-04-11 | 2007-05-16 | Xenon Pharmaceuticals Inc | Compuestos espiroheterociclicos y sus usos como agentes terapeuticos |
CL2007002950A1 (es) | 2006-10-12 | 2008-02-01 | Xenon Pharmaceuticals Inc | Uso de compuestos derivados de espiro-oxindol en el tratamiento de hipercolesterolemia, hiperplasia benigna de prostata, pruritis, cancer |
EP2234491A4 (en) * | 2007-12-20 | 2010-12-22 | Teva Womens Health Inc | DOSAGE SCHEMES AND PHARMACEUTICAL COMPOSITIONS AND PACKAGING FOR EMERGENCY CONTRACEPTION |
US8263606B2 (en) | 2008-10-17 | 2012-09-11 | Xenon Pharmaceuticals Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
EP2350091B1 (en) | 2008-10-17 | 2015-06-03 | Xenon Pharmaceuticals Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
WO2011029782A1 (en) * | 2009-09-11 | 2011-03-17 | Bayer Schering Pharma Aktiengesellschaft | Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs |
EP2733145A1 (en) | 2009-10-14 | 2014-05-21 | Xenon Pharmaceuticals Inc. | Synthetic methods for spiro-oxindole compounds |
PE20121699A1 (es) | 2010-02-26 | 2012-12-22 | Xenon Pharmaceuticals Inc | Composiciones farmaceuticas del compuesto espiro-oxindol para administracion topica |
EP3205648A1 (en) | 2010-06-10 | 2017-08-16 | Seragon Pharmaceuticals, Inc. | Estrogen receptor modulators and uses thereof |
EA029559B1 (ru) | 2011-12-14 | 2018-04-30 | Серагон Фармасьютикалс, Инк. | Фторированные модуляторы рецепторов эстрогенов и их применение |
WO2016127068A1 (en) | 2015-02-05 | 2016-08-11 | Teva Pharmaceuticals International Gmbh | Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5461065A (en) * | 1993-10-15 | 1995-10-24 | Eli Lilly And Company | Methods for inhibiting endometriosis |
DE4335876A1 (de) | 1993-10-17 | 1995-04-20 | Schering Ag | Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen |
US5446053A (en) * | 1993-12-21 | 1995-08-29 | Eli Lilly And Company | Methods of inhibiting dysfunctional uterine bleeding |
US5633011A (en) * | 1994-08-04 | 1997-05-27 | Alza Corporation | Progesterone replacement therapy |
US6653297B1 (en) * | 1997-07-03 | 2003-11-25 | Medical College Of Hampton Roads | Control of selective estrogen receptor modulators |
US6326392B1 (en) * | 1997-11-06 | 2001-12-04 | American Home Products Corporation | Anti-estrogen plus progestin containing oral contraceptives |
PT1123082E (pt) * | 1998-10-23 | 2006-06-30 | Aventis Pharma Sa | Preparacoes para aplicacao topica de substancias de actividade antiandrogenica |
US6331562B1 (en) * | 1998-12-30 | 2001-12-18 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
JP2002533360A (ja) * | 1998-12-31 | 2002-10-08 | スージェン・インコーポレーテッド | 蛋白質キナーゼ活性を調節するためおよび癌の化学療法において用いるための3−ヘテロアリーリデニル−2−インドリノン化合物 |
US6407101B1 (en) * | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
US6355648B1 (en) * | 1999-05-04 | 2002-03-12 | American Home Products Corporation | Thio-oxindole derivatives |
US6391907B1 (en) | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
JP2003525796A (ja) | 1999-08-26 | 2003-09-02 | オートモーティブ システムズ ラボラトリー インコーポレーテッド | 磁気センサ |
US6566372B1 (en) * | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
US20010034340A1 (en) * | 2000-03-20 | 2001-10-25 | American Home Products Corporation | Hormone replacement therapy |
UA73119C2 (en) | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
CZ2003514A3 (cs) * | 2000-08-23 | 2003-10-15 | Akzo Nobel N. V. | Fluorenové deriváty a jejich analogy |
CN1665510A (zh) * | 2002-06-25 | 2005-09-07 | 惠氏公司 | 作为pr调节剂的环硫代氨基甲酸酯衍生物的衍生物和其用于治疗皮肤病的用途 |
TW200404548A (en) * | 2002-06-25 | 2004-04-01 | Wyeth Corp | Pharmaceutical composition containing cyclothiocarbamate derivatives in treatment of hormone-related conditions |
IL165395A0 (en) * | 2002-06-25 | 2006-01-15 | Wyeth Corp | Use of thio-oxubdile derivatives in treatment of hormone-related conditions |
US7115649B2 (en) * | 2002-06-25 | 2006-10-03 | Wyeth | Methods of treating skin disorders using thio-oxindole derivatives |
-
2003
- 2003-06-23 IL IL16539503A patent/IL165395A0/xx unknown
- 2003-06-23 WO PCT/US2003/019710 patent/WO2004000225A2/en not_active Application Discontinuation
- 2003-06-23 EP EP03739264A patent/EP1531806A4/en not_active Withdrawn
- 2003-06-23 US US10/601,438 patent/US7488734B2/en not_active Expired - Fee Related
- 2003-06-23 RU RU2005101635/15A patent/RU2005101635A/ru not_active Application Discontinuation
- 2003-06-23 AU AU2003245637A patent/AU2003245637A1/en not_active Abandoned
- 2003-06-23 CN CN038147807A patent/CN1662234A/zh active Pending
- 2003-06-23 BR BR0312054-6A patent/BR0312054A/pt not_active IP Right Cessation
- 2003-06-23 CA CA002489813A patent/CA2489813A1/en not_active Abandoned
- 2003-06-23 JP JP2004516125A patent/JP2005535623A/ja active Pending
- 2003-06-23 TW TW092116982A patent/TW200407124A/zh unknown
- 2003-06-23 MX MXPA04012419A patent/MXPA04012419A/es unknown
- 2003-06-24 AR ARP030102255A patent/AR040339A1/es unknown
-
2004
- 2004-11-29 NO NO20045217A patent/NO20045217L/no not_active Application Discontinuation
- 2004-12-08 CR CR7610A patent/CR7610A/es unknown
- 2004-12-23 ZA ZA200410409A patent/ZA200410409B/xx unknown
-
2005
- 2005-01-25 EC EC2005005574A patent/ECSP055574A/es unknown
-
2008
- 2008-12-17 US US12/336,588 patent/US8242098B2/en not_active Expired - Fee Related
-
2012
- 2012-05-08 US US13/466,375 patent/US20120220558A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1531806A4 (en) | 2005-09-21 |
ECSP055574A (es) | 2005-04-18 |
US20120220558A1 (en) | 2012-08-30 |
BR0312054A (pt) | 2005-10-18 |
US7488734B2 (en) | 2009-02-10 |
CN1662234A (zh) | 2005-08-31 |
WO2004000225A3 (en) | 2004-06-10 |
US8242098B2 (en) | 2012-08-14 |
MXPA04012419A (es) | 2005-04-19 |
WO2004000225A2 (en) | 2003-12-31 |
CA2489813A1 (en) | 2003-12-31 |
CR7610A (es) | 2006-05-29 |
US20040002535A1 (en) | 2004-01-01 |
AR040339A1 (es) | 2005-03-30 |
AU2003245637A1 (en) | 2004-01-06 |
ZA200410409B (en) | 2006-05-31 |
IL165395A0 (en) | 2006-01-15 |
EP1531806A2 (en) | 2005-05-25 |
RU2005101635A (ru) | 2005-08-10 |
JP2005535623A (ja) | 2005-11-24 |
US20090099223A1 (en) | 2009-04-16 |
TW200407124A (en) | 2004-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20045217L (no) | Anvendelse av tio-oxindolderivater for behandling av hormon relaterte tilstander | |
NO20045216L (no) | Anvendelse av cyklotiokarbamatderivater for behandling av hormon relaterte tilstander | |
NO20065499L (no) | Kontroll av gjennombruddsblodning i utvidede hormonelle svangerskapsforebyggende regimer | |
NO20062679L (no) | Nye 17 β -hydroksysteroid-dehydrogenase-type 1-inhibitorer | |
NO20063599L (no) | Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
NO20065678L (no) | 3-(4-heteroarylcykloheksylamino) cyklopentankarboksamider som modulatorer for kjemokinreseptorer. | |
NO20070487L (no) | 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer. | |
NO20050832L (no) | Selektive estrogenreseptormodulatorer inneholdende en fenylsulonylgruppe | |
PE20070341A1 (es) | Derivados de pirrol como moduladores del receptor de progesterona | |
MY142048A (en) | Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms) | |
NO20083065L (no) | Nye N-sulfamoylpiperidinamider for profylakse eller behandling av overvekt og beslektede tilstander | |
NO20080354L (no) | Benzofuranylderivater som 5-HT6-reseptorinhibitorer | |
NO20080441L (no) | Benzofuranonderivater som ikke-steroide progesteronreseptormodulatorer | |
ATE460412T1 (de) | Trisubstituierte thiophene als progesteronreceptor-modulatoren | |
NO20090457L (no) | Oksazolidon derivativer som PR modulatorer | |
NZ515353A (en) | Cyclothiocarbamate derivatives as progesterone receptor modulators | |
MX2009009514A (es) | Heterociclos sulfonilados utiles para la modulacion del receptor de progesterona. | |
UA85203C2 (en) | 17β HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS | |
NO20080440L (no) | Ikke-steroide progesteronreseptormodulatorer | |
ATE448215T1 (de) | Selektive östrogen-rezeptor-modulatoren | |
WO2008113851A3 (en) | Novel c11 modified retrosteroids as progesterone receptor modulator compounds | |
WO2008109055A3 (en) | Cyanopyrrole sulfonamides useful for modulation of the progesterone receptor | |
ATE412631T1 (de) | Indolderivate als progesteron-rezeptormodulatoren | |
WO2003061655A8 (en) | 2-aminothiazole allosteric enhancers of a1 adenosine receptors | |
NO20050995L (no) | Sammensetning inneholdende et androgent 11β- halogensteroid og et progestasjonelt hormon samt mannlig prevensjonsmiddel basert pa denne sammensetningen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |